1. Spreafico F, Ferrari A, Mascarin M, Collini P, Morosi C, Biasoni D, et al. Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: Lessons learned from the pediatric experience. Cancer Metastasis Rev. 2019;38(4):683–94. 10.1007/s10555-019-09831-3

2. Vallejo Yepes C, Bermudez M, Camacho-Nieto D, Mesa J, Bruges R. Adult Wilms’ tumor: Case report and literature review. Cureus. 2021;13(6):e15524. 10.7759/cureus.15524

3. Sudour-Bonnange H, Coulomb-Lhermine A, Fantoni JC, Escande A, Brisse HJ, Thebaud E, Verschuur A. Standard of care for adult Wilms tumor? From adult urologist to pediatric oncologist. A retrospective review. Bull Cancer. 2021;108(2):177–86. 10.1016/j.bulcan.2020.09.007

4. Bajaj S, Gandhi D, Shah J, Serhal M, Sharma S. Adult Wilms tumor: An unusual case report with dedicated literature review. Clin Imaging. 2022;83:138–43. 10.1016/j.clinimag.2021.12.025

5. Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43(9):705–15. 10.1136/jmg.2006.041723

6. Argani P, Tickoo SK, Matoso A, Pratilas CA, Mehra R, Tretiakova M, et al. Adult Wilms tumor: Genetic evidence of origin of a subset of cases from metanephric adenoma. Am J Surg Pathol. 2022;46(7):988–99. 10.1097/PAS.0000000000001864

7. Tsukahara K, Mayer OH. Thoracic insufficiency syndrome: Approaches to assessment and management. Paediatr Respir Rev. 2022;44:78–84. 10.1016/j.prrv.2022.02.003

8. Keppler-Noreuil KM, Adam MP, Welch J, Muilenburg A, Willing MC. Clinical insights gained from eight new cases and review of reported cases with Jeune syndrome (asphyxiating thoracic dystrophy). Am J Med Genet A. 2011;155A(5):1021–32. 10.1002/ajmg.a.33892

9. Poyner SE, Bradshaw WT. Jeune syndrome: Considerations for management of asphyxiating thoracic dystrophy. Neonatal Netw. 2013;32(5):342–52. 10.1891/0730-0832.32.5.342

10. Mayer OH. Chest wall hypoplasia—Principles and treatment. Paediatr Respir Rev. 2015;16(1):30–4. 10.1016/j.prrv.2014.10.012

11. Parsons LN, Mullen EA, Geller JI, Chi YY, Khanna G, Glick RD, et al. Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children’s Oncology Group study AREN03B2. Cancer. 2020;126(12):2866–71. 10.1002/cncr.32855

12. Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, et al. Wilms tumour. Nat Rev Dis Primers. 2021;7(1):75. 10.1038/s41572-021-00308-8

13. Diniz G. Histopathological and molecular characteristics of Wilms tumor. In: van den Heuvel-Eibrink MM, editor. Wilms tumor. Brisbane (AU); 2016, pp. xxxx. 10.15586/codon.wt.2016.ch3

14. Cone EB, Dalton SS, Van Noord M, Tracy ET, Rice HE, Routh JC. Biomarkers for Wilms tumor: A systematic review. J Urol. 2016;196(5):1530–5. 10.1016/j.juro.2016.05.100

15. Huszno J, Starzyczny-Slota D, Jaworska M, Nowara E. Adult Wilms’ tumor—Diagnosis and current therapy. Cent Eur J Urol. 2013;66(1):39–44. 10.5173/ceju.2013.01.art12

16. Dumoucel S, Gauthier-Villars M, Stoppa-Lyonnet D, Parisot P, Brisse H, Philippe-Chomette P, et al. Malformations, genetic abnormalities, and Wilms tumor. Pediatr Blood Cancer. 2014;61(1):140–4. 10.1002/pbc.24709

17. Liu EK, Suson KD. Syndromic Wilms tumor: A review of predisposing conditions, surveillance and treatment. Transl Androl Urol. 2020;9(5):2370–81. 10.21037/tau.2020.03.27

18. Maciaszek JL, Oak N, Nichols KE. Recent advances in Wilms’ tumor predisposition. Hum Mol Genet. 2020;29(R2):R138–49. 10.1093/hmg/ddaa091

19. Hol JA, Kuiper RP, van Dijk F, Waanders E, van Peer SE, Koudijs MJ, et al. Prevalence of (Epi)genetic predisposing factors in a 5-year Unselected National Wilms Tumor Cohort: A comprehensive clinical and genomic characterization. J Clin Oncol. 2022;40(17):1892–902. 10.1200/JCO.21.02510

20. Hont AB, Dumont B, Sutton KS, Anderson J, Kentsis A, Drost J, et al. The tumor microenvironment and immune targeting therapy in pediatric renal tumors. Pediatr Blood Cancer. 2023;70(Suppl 2):e30110. 10.1002/pbc.30110

21. Zhang L, Jiao H, Shen M, Liu W, Li Z, Lin J. Clinical significance of tumoral PD-L1 expression in Wilms tumors. J Pediatr Urol. 2022;18(1):14 e1–e8. 10.1016/j.jpurol.2021.10.015

22. Popov SD, Sebire NJ, Vujanic GM. Wilms’ tumour—Histology and differential diagnosis. In: van den Heuvel-Eibrink MM, editor. Wilms tumor. Brisbane (AU); 2016, pp. xxx. 10.15586/codon.wt.2016.ch1

23. Hennigar RA, O’Shea PA, Grattan-Smith JD. Clinicopathologic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol. 2001;8(5):276–89. 10.1097/00125480-200109000-00005

24. Pan CC, Tseng CE, Kuroda N, Yano M, Yasuda M, Nagashima Y, et al. Molecular characterization of metanephric adenoma, epithelial Wilms tumor, and overlap lesions: An integrated whole-exome and transcriptome sequencing analysis. Appl Immunohistochem Mol Morphol. 2022;30(4):257–63. 10.1097/PAI.0000000000000996

25. de Vries-Brilland M, Sionneau B, Dutriaux C, Blay JY, Ravaud A, Gross-Goupil M. Successful treatment of metastatic adult Wilms tumor with anti-BRAF treatment: A case report and a brief review of the literature. Clin Genitourin Cancer. 2019;17(4):e721–3. 10.1016/j.clgc.2019.02.012

26. Ross A, Gomez O, Wang X, Lu Z, Abdelhafeez H, Davidoff AM, et al. Timing of adjuvant chemotherapy after laparotomy for Wilms tumor and neuroblastoma. Pediatr Surg Int. 2021;37(11):1585–92. 10.1007/s00383-021-04968-1

27. Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3):2022-vol3.

28. Beckwith JB, Zuppan CE, Browning NG, Moksness J, Breslow NE. Histological analysis of aggressiveness and responsiveness in Wilms’ tumor. Med Pediatr Oncol. 1996;27(5):422–8. 10.1002/(SICI)1096-911X(199611)27:53.0.CO;2-O

29. Weirich A, Leuschner I, Harms D, Vujanic GM, Troger J, Abel U, et al. Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH. Ann Oncol. 2001;12(3):311–9. 10.1023/A:1011167924230

30. Verschuur AC, Vujanic GM, Van Tinteren H, Jones KP, de Kraker J, Sandstedt B. Stromal and epithelial predominant Wilms tumours have an excellent outcome: The SIOP 93 01 experience. Pediatr Blood Cancer. 2010;55(2):233–8. 10.1002/pbc.22496